Status:
UNKNOWN
Association Between Non-alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Calcification
Lead Sponsor:
Ziv Hospital
Conditions:
Coronary Artery Calcification
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Coronary artery disease are 8 times more prevalent in patients with NAFLD then the general population and are being considered the most common cause of death. Cardiac CT is a reliable non invasive met...
Detailed Description
Coronary artery disease are 8 times more prevalent in patients with NAFLD that the general population and are being considered the most common cause of death. Cardiac CT is a reliable non invasive met...
Eligibility Criteria
Inclusion
- Patients who will undergo cardiac CT for patients with low to intermediate risk for CAD
Exclusion
- Patients with PCI or CABG will be excluded
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01158066
Start Date
August 1 2011
End Date
March 1 2012
Last Update
April 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziv medical center liver unit
Safed, Israel, Israel, 13100